Cell size fundamentally affects all biosynthetic processes by determining the scale of organelles and influencing surface transport 1, 2 . Although extensive studies have identified many mutations affecting cell size, the molecular mechanisms underlying size control have remained elusive 3 . In the budding yeast Saccharomyces cerevisiae, size control occurs in G1 phase before Start, the point of irreversible commitment to cell division 4, 5 . It was previously thought that activity of the G1 cyclin Cln3 increased with cell size to trigger Start by initiating the inhibition of the transcriptional inhibitor Whi5 (refs 6-8) . Here we show that although Cln3 concentration does modulate the rate at which cells pass Start, its synthesis increases in proportion to cell size so that its total concentration is nearly constant during pre-Start G1. Rather than increasing Cln3 activity, we identify decreasing Whi5 activitydue to the dilution of Whi5 by cell growth-as a molecular mechanism through which cell size controls proliferation. Whi5 is synthesized in S/G2/M phases of the cell cycle in a largely sizeindependent manner. This results in smaller daughter cells being born with higher Whi5 concentrations that extend their pre-Start G1 phase. Thus, at its most fundamental level, size control in budding yeast results from the differential scaling of Cln3 and Whi5 synthesis rates with cell size. More generally, our work shows that differential size-dependency of protein synthesis can provide an elegant mechanism to coordinate cellular functions with growth.
To control size, proliferating cells tie division to growth. However, the molecular mechanisms by which growth triggers division are poorly understood 3, 9, 10 . In S. cerevisiae, which divides asymmetrically into a larger mother and smaller daughter cell, size control takes place in the first G1 phase of daughter cells 5, 11, 12 . Progression through G1 is promoted by the upstream G1 cyclin Cln3 in complex with the cyclindependent kinase Cdk1. This Cln3-Cdk1 complex is thought to partly inactivate the transcriptional inhibitor Whi5 (refs 13, 14) . Inactivation of Whi5 relieves inhibition of the transcription factor SBF, whose transcriptional activation completes a positive feedback loop committing the cell to division 4 . While its upstream position in the G1 regulatory network suggests that Cln3 is the trigger, its concentration does not clearly increase during G1 (refs 8, 15) . Although Cln3 is a nuclear protein, the size of the yeast nucleus is proportional to cell size, so that the measured cellular concentrations reflect nuclear concentrations 16 . This leads to the question of why G1 progression is size-dependent when the putative trigger protein Cln3 does not increase in concentration.
Two prevailing models propose mechanisms to generate a sizedependent signal from the constant Cln3 concentration. One model proposes that the increasing number of Cln3 molecules is titrated against the fixed number of SBF-binding sites on the genome 6 . This DNA-titration serves to convert the constant Cln3 concentration to an increasing activity at its target sites on the genome. The other model proposes that Cln3 is retained at the endoplasmic reticulum and is rapidly released upon sufficient growth-dependent accumulation of the chaperone Ydj1 (refs 7, 17) . Here we perform a series of experiments whose results are inconsistent with the two existing models.
Instead, we identify a new molecular mechanism for cell size control that does not require Cln3 activity increasing with cell size. Rather, we show that cell size promotes G1 progression by diluting the primary target of Cln3, Whi5 (Fig. 1a) .
To determine how the G1 regulatory network implements size control, we first examined how the concentration of key regulators changes through G1. We grew cells using ethanol as the carbon source to generate small daughter cells subject to strong cell size control 5 . We restricted our attention to these daughter cells, and used time-lapse microscopy to measure the concentration of proteins tagged with the fluorescent protein mCitrine and expressed from the endogenous locus ( Fig. 1b-g and Extended Data Fig. 1a ). The concentration of wild-type (WT) Cln3 cannot be measured with this approach owing to its rapid and constitutive degradation. We therefore examined two mutants expressing stabilized proteins (CLN3-11A and CLN3-1 (refs [18] [19] [20] ; Extended Data Fig. 1b ). Consistent with previous bulk measurements of WT Cln3, Cln3-11A and Cln3-1 concentrations are constant through G1 (Fig. 1b) . Moreover, we observed no changes in Cln3-11A localization (Extended Data Fig. 2 ). This is inconsistent with the Cln3 retention model, which predicts a rapid increase in nuclear Cln3 concentration in mid-G1 (ref. 7) . Similarly, the concentrations of the key G1 regulators Swi4, Whi3, and Bck2 are nearly constant through G1 ( Fig. 1c-e ). In sharp contrast, we found that the concentration of the cell cycle inhibitor Whi5 strongly decreases through G1 ( Fig. 1f and Extended Data Fig. 3a ). This suggests that the dilution of the cell cycle inhibitor Whi5 is a size-dependent signal promoting cell cycle progression ( Fig. 1a ). Such an inhibitor-dilution model 21 represents a qualitatively distinct mechanism of cell size control that does not require a size-dependent increase in Cln3-activity.
While inhibitor dilution explains how growth drives proliferation, it does not immediately explain why smaller-born cells grow more in G1. This would also require that smaller-born cells start G1 with a higher concentration of Whi5. Indeed, we found that the concentration of Whi5 at cell birth monotonically decreases with cell size, whereas the concentration of Cln3-11A and Cln3-1 at cell birth is independent of cell size ( Fig. 2a, b ). We confirmed that Whi5 is diluted in G1 using quantitative immunoblots ( Fig. 2c ). Finally, for a given birth size, diploid cells are born with a much higher Whi5 concentration ( Fig. 2d and Extended Data Fig. 4a ), which is consistent with the long-standing observation that cell size scales linearly with ploidy 3, 22 . Taken together, our data support a size control model in which all cells are born with a similar dose of Whi5, which they dilute by growth to progress through G1.
Inhibitor-dilution results in size-dependent cell cycle progression because smaller cells are born with higher Whi5 concentrations. To identify the origin of this size-dependent Whi5 concentration, we measured the rate of Whi5 synthesis throughout the cell cycle. We found that Whi5 is a stable protein, synthesized primarily during S/G2/M ( Fig. 2e and Extended Data Figs 3b and 5a), consistent with previous mRNA measurements 23 . Whi5 is differentially partitioned so that, following division, its concentration in daughter cells is consistently higher than in mother cells (Extended Data Fig. 6a, b ). Critically, during S/G2/M, Whi5 is synthesized at a rate largely independent of cell size ( Fig. 2e , f and Extended Data Figs 3b and 4b). Since S/G2/M duration weakly depends on mother cell size (Extended Data Fig. 6c ), small and large cells produce similar amounts of Whi5. This results in larger budded cells having a lower Whi5 concentration just before division (Extended Data Fig. 6d ). Since larger mother cells produce larger daughter cells (Extended Data Fig. 6e ), this explains the inverse correlation between Whi5 concentration and cell size at birth, which is essential for the inhibitor-dilution size control model.
The size-independent synthesis rate of Whi5 during S/G2/M shows it is not limited by the general biosynthetic capacity of the cell, which increases with cell size. This contrasts with the expectation that transcriptional and translational outputs scale with cell size 24 . Indeed, mCitrine-Cln3-11A synthesis in G1 is proportional to cell size ( Fig. 2g and Extended Data Fig. 5b-c) . Thus, the differential size scaling of Cln3 and Whi5 synthesis lies at the heart of cell size control in budding yeast.
Since ploidy is an important determinant of cell size, we decided to examine how it impacts the differential synthesis of Cln3 and Whi5. As expected for the majority of genes, whose synthesis is limited by the biosynthetic capacity of the cell, Cln3-11A synthesis in a diploid cell is comparable to the synthesis of a similarly sized haploid cell, despite having two copies of mCitrine-CLN3-11A ( Fig. 2g ). Thus, in diploids the biosynthetic machinery is split between the two copies of the genome. Consistently, a hemizygous diploid synthesizes mCitrine-Cln3-11A protein at a much lower rate than a similarly sized haploid or homozygous diploid ( Fig. 2g ). In sharp contrast, Whi5-mCitrine synthesis is similar and size-independent in hemizygous diploid and haploid cells ( Fig. 2f and Extended Data Fig. 4b ). Moreover, a homozygous diploid produces Whi5 at approximately twice the rate, similar to a haploid with two copies of WHI5 ( Fig. 2f and Extended Data Fig. 4b ). Thus, the rate of Whi5 synthesis is determined by the number of copies of the gene and is independent of cell size and ploidy.
While the inhibitor-dilution model takes into account cell-to-cell variability in birth size, it does not yet include the fact that cells born the same size will vary in how much they grow before Start 5 (Fig. 3a) . For a population of similarly sized pre-Start cells, only a fraction will pass Start within the short time interval between movie frames. This allows us to define a rate as this fraction divided by the time interval ( Fig. 3b ; see Methods). In our inhibitor-dilution model, the rate at which cells pass Start is determined by the concentrations of Whi5 and Cln3. If Cln3 concentration is constant in pre-Start cells, the Whi5 concentration alone should predict the rate at which cells progress through Start. To test this model, we generated haploid strains containing one, two, and four copies of WHI5-mCitrine. We note these experiments are in a bck2D background, where Cln3 is essential 25 . As expected, cells containing two and four copies of WHI5 produced proportionally more Whi5 protein, were larger, and exhibited a decreased size-dependent rate of progression through Start ( Fig. 3b and Extended Data Fig. 4c, d ). We note that these experiments were performed using cells expressing WT Cln3, which is suggested to be at constant concentration in G1 based on our measurements of Cln3-11A and Cln3-1. In complete agreement with an inhibitor-dilution model with a size-independent activator, the concentration of Whi5 alone predicts the rate at which cells progress through Start for all three strains ( Fig. 3c ). Consistently, the relationship between the rate of progression through Start and Whi5 concentration was not changed in hcm1D cells that lack a transcription factor promoting WHI5 expression 23 (Extended Data Fig. 7 ).
In our inhibitor-dilution model, Cln3 concentration determines the fraction of active Whi5. Thus, for a given Whi5 concentration, it should be possible to drive cell cycle entry by sufficiently increasing Cln3 concentration. To test this prediction, we constructed a bck2D strain with mCitrine-CLN3-11A under control of the methionineregulated MET25 promoter. In this strain, repressing CLN3-11A expression arrests cells in G1, during which they continue to grow. Thus, by first arresting cells for varying durations and then inducing CLN3-11A for varying lengths of time, we were able to examine a wide range of cell sizes and Cln3 and Whi5 concentrations ( Fig. 4a ). We binned cells by size, which determines Whi5 concentration, and performed a logistic regression to determine the critical Cln3 concentration (pulse amplitude that results in half the cells budding; for example, Fig. 4b and Extended Data Fig. 8 ). Larger cells required lower Cln3-11A concentrations to enter the cell cycle (Extended Data Fig. 8d ), consistent with previous results showing that larger G1 cells were more sensitive to Cln1 expression 26 . Next, we used a strain that carries MET25pr-CLN3-11A and WHI5-mCitrine to measure the average Whi5 concentration as a function of cell size under the same arrest conditions (Extended Data Fig. 8e ). The critical Cln3 concentration increases with Whi5 concentration as predicted by the Whi5-dilution model (Fig. 4c) .
The Whi5-dilution model, unlike DNA-titration models, does not explicitly depend on the DNA content of the cell and predicts that the relationship between the critical Cln3 concentration and Whi5 concentration should be independent of ploidy. To test this, we repeated the same set of pulsing experiments using diploid strains and found a similar relationship between the critical Cln3 and Whi5 concentrations ( Fig. 4c ; P . 0.05). This is consistent with experiments showing that introducing heterologous DNA through yeast artificial chromosomes does not affect progression through G1 (ref. 27 ). However, we note that increased ploidy delays progression through S/G2/M, which results in larger daughter cells and mean population size ( Fig. 2f and Extended Data Fig. 9 ).
To determine that the relevant parameter for Start is Whi5 concentration, rather than cell size, we repeated the pulse experiments with a strain that carries a hormone-inducible promoter expressing a WHI5-mCherry allele in addition to the MET25pr-mCitrine-CLN3-11A allele (Fig. 4d ). This allowed us to generate cells of different sizes containing similar Whi5 concentrations. As predicted, the probability of a cell passing Start increases with Cln3 concentration (P , 10 25 ), decreases with Whi5 concentration (P , 10 25 ), but is independent of cell size (P . 0.5) ( Fig. 4e ).
Taken together, our data support a new inhibitor-dilution model for size control in budding yeast. In this model, cell growth dilutes the cell cycle inhibitor Whi5 to drive progression through the cell cycle, whereas Cln3 concentration and activity remain constant. In this model, any regulation of Cln3 transcription 28 , translation 29 , or stability 30 that affects Cln3 concentration can be used to modulate cell size in different environmental conditions. While inhibitor dilution immediately leads to a growth requirement, this requirement is not necessarily different for larger-and smaller-born daughter cells, which is necessary for cell size control. For the inhibitor-dilution mechanism to control cell size it is crucial that the amount of Whi5 that cells are born with does not scale with size as we have shown here. In contrast, the cell cycle activator Cln3 is produced in proportion to size. This differential size-dependency of cell cycle activator and inhibitor synthesis constitutes the basis of size control in budding yeast ( Fig. 4f ).
Inhibitor-dilution is an elegant mechanism to control cell size independently of other aspects of cell geometry. In rod-shaped cells, such as fission yeast and bacteria, geometric mechanisms measuring lengths or surface areas can sensitively measure cell size because these metrics are directly proportional. However, such geometric measurements would perform poorly in near-spherical budding yeast, where intracellular lengths scale with the cube root of cell volume, so that a doubling of cell size results in only an ,25% increase in characteristic length. Geometric mechanisms are also unlikely to be applicable to more irregularly shaped metazoan cells. In contrast, inhibitor-dilution mechanisms can measure cell volume with no geometric constraints. All that is required is the differential size scaling of a cell cycle activator relative to an inhibitor. Because of the simplicity of this requirement, we anticipate the wide application of inhibitor-dilution mechanisms to control cell size.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. MET25pr-mCitrine-CLN3-11A bck2D cells are arrested in G1 for 2-4 h by addition of methionine to create G1 daughter cells of varying size. Following arrest, mCitrine-CLN3-11A expression is induced for varying amounts of time (0-60 min). b, Cells are binned by size and a logistic regression is then used to calculate the fraction of cells driven into the cell cycle as a function of the maximum Cln3-11A concentration produced by the exogenous pulse. Regression shown for 200-250 fl cells to determine the critical Cln3 concentration, where 50% of the cells bud. Single-cell data are marked green (budding) or red (not budding). c, The critical Cln3-11A concentration increases with Whi5 concentration, which was determined independently for each size bin (Extended Data Fig. 8 ). Haploid (filled circles, n 5 1195) and diploid (open squares, n 5 405) cells show a similar relationship between Whi5 and critical Cln3-11A concentrations (P . 0.05). d, To decouple cell size and Whi5 concentration, the pulse experiment is repeated with a strain expressing both WHI5 and CLN3-11A from exogenously controlled promoters (MET25pr-mCitrine-CLN3-11A LexApr-WHI5-mCherry bck2D). Whi5 concentration and the duration of G1 arrest before the Cln3 pulse are varied. e, Data are displayed using two size and three Whi5 concentration bins. Higher Cln3 pulse amplitudes are needed to drive cells with higher Whi5 levels into the cell cycle, while no significant difference is observed for smaller and larger cells (P . 0.5, n 5 471), which we note also have different DNA concentrations. f, Differential size-scaling of protein synthesis underlies budding yeast size control and provides a general mechanism to measure cell size independently of cell geometry.
METHODS
Imaging and image analysis. All experiments were performed using a Cellasic microfluidics device with Y04C plates. A Zeiss Observer Z1 microscope with an automated stage using a plan-apo 63X/1.4NA oil immersion objective was used to take images every 3 min. Focusing was performed using automated Definite Focus hardware. Strains expressing mCitrine fusion proteins were exposed for 400 ms using the Colibri 505 LED module at 25% power. Whi5-mCherry was imaged by exposure for 500 ms using the Colibri 540-80 LED module at 50% power. Under these illumination conditions, we did not observe detectable photobleaching (Extended Data Fig. 10a ). Cell and nuclear segmentation and quantification of fluorescence signals was performed as in ref. 31 . We subtracted the size-dependent autofluorescence signal as determined from comparable experiments with unlabelled strains (Extended Data Fig. 10b, c) to measure the total fluorescence intensity in single cells from fluorescent-fusion proteins. Total fluorescence intensity is proportional to the protein amount. To determine protein concentration, we calculate cell volume from the phase image segmentation by assuming rotational symmetry around the major axis in the x-y plane. We confirmed that localization of Whi5 did not significantly affect concentration measurements (Extended Data Fig. 3c, d) . Experimental design and statistical analysis. All data shown were obtained from at least two independent experiments. For each experiment, we collected data from 10 to 20 imaging positions. Comparison of biological replicates allowed us to assay for systematic errors. This resulted in sufficient data for our statistical comparisons. No statistical methods were used to predetermine sample size. The experiments were not randomized. The investigators were not blinded to allocation during experiments and outcome assessment. Cell-cycle phase analysis. After automated segmentation, we manually annotated pedigrees and determined time points of cell birth, bud emergence, and cytokinesis from phase images. We only included daughter cells that were born during the experiment in our analyses. For cells shown in Figs 1 and 2, we estimated G1 using cytokinesis and bud emergence. Whi5 enters the nucleus ,9 min before cytokinesis 5 , which can also be detected by visual inspection of phase images. For Fig. 3 , we estimated the time of Start, the point of commitment to cell division beyond which haploid cells no longer arrest in response to an abrupt exposure to a high concentration of mating pheromone. Start in haploid cells corresponds to the point where ,50% of the peak nuclear Whi5 has been removed from the nucleus 4 . Start takes place ,12 min before the full exit of Whi5-mCitrine from the nucleus in cells growing on 2% glycerol and 1% ethanol. For 2 3 WHI5-mCitrine and 4 3 WHI5-mCitrine strains, we used 12 min before full Whi5 exit as a proxy for Start. Whi5 and Cln3 synthesis rate estimates. To estimate Whi5 synthesis rates, we analysed time series for the amount of Whi5-mCitrine in the S/G2/M phase of the cell cycle (the budded phase). This phase was determined as described above. We fitted a line to the data and took the slope as an estimate of the Whi5 synthesis rate because Whi5 is a highly stable protein (Extended Data Fig. 5a ). Synthesis rate estimates for individual cells are plotted against the cell size at the time of bud emergence (Extended Data Fig. 4b) ; mean values for size-binned data are shown in Fig. 2f . We used a similar method to estimate the much lower Whi5 synthesis rate during G1 (Extended Data Fig. 3b ).
To estimate Cln3 synthesis rates during G1, we analysed time series for individual cells expressing mCitrine-Cln3-11A. For each cell, we estimated the Cln3-11A synthesis rate, k, over a 30-min interval in which we assumed it was constant. This is valid because a cell growing on glycerol/ethanol changes little in size during a 30-min interval. We excluded cells with G1 durations shorter than 30 min. We assumed protein degradation can be characterized by an exponential decay constant t , 83 min that we independently measured (Extended Data Fig. 5c ). We take N to be the number of Cln3-11A molecules, so that dN/dt 5 k 2 1 t N, which can be solved to yield the number of Cln3-11A molecules
Here, N 0 denotes the amount of Cln3 at the beginning of the interval. N 0 and k are then determined from fitting this equation to the data. The synthesis estimate k is then plotted against the cell size at the beginning of the interval (Fig. 2g ).
Estimate of rate at which cells pass Start. The Start transition is a highly stochastic process 5 , which means that cells born at the same size will vary in how much time they spend growing in pre-Start G1. Thus, for a population of similarly sized pre-Start cells, only a fraction will pass Start within a given time interval. To quantify this phenomenon, we calculate the fraction of pre-Start cells within a size interval that pass Start within one frame of our movie (3 min). Thus, we define the rate at which cells pass Start as a function of cell size as the fraction of cells within the size bin that passed Start divided by the time interval between movie frames. Similarly, we can also define the rate at which cells pass Start as a function of Whi5 concentration by grouping cells by Whi5 concentration rather than cell size. We note that the Start transition is defined in the cell-cycle phase analysis section above based on ref. 4 . This analysis, based on binning cells by size or Whi5 concentration, was used to obtain the jagged lines in Fig. 3b , c. The smooth curves, and associated 95% confidence intervals, were obtained by logistic regression of the unbinned data set as follows. For each frame, a pre-Start cell is described by three numbers: cell size, Whi5 concentration, and whether or not that cell passed Start in the next 3 min (51 if the cell passed Start; 50 otherwise). Data from all time points for all pre-Start daughter cells were pooled into a large matrix with three columns. We then performed a logistic regression using the MATLAB function glmfit to estimate the probability of a cell passing Start as a function of either cell size or Whi5 concentration. We note that Fig. 3c shows that the instantaneous probability for a cell to pass Start is determined by the Whi5 concentration, not volume. However, this does not necessarily mean that cells with different Whi5 copy number need to reach the same Whi5 concentration. Consider two cells born with different Whi5 concentrations. The one with the higher Whi5 concentration has to grow for a certain amount of time to reach the initial Whi5 concentration of the second cell. Since the probability for passing Start is always non-zero, there is a certain chance that the cell enters the cell cycle even before reaching the birth concentration of the one with lower Whi5 concentration. Thus, on average, cells born with higher initial Whi5 concentrations will pass Start at higher Whi5 concentrations. Adding an extra copy of Whi5 does result in an increase of cell size, however, cell size is not doubled. Thus, 2 3 WHI5 cells are on average born with higher Whi5 concentrations, but also pass Start at higher Whi5 concentrations, even though the instantaneous probability of passing Start as a function of Whi5 is the same as in WT cells.
We also note that the series of experiments described in Figs 3 and 4 were performed in a bck2D background. In the absence of Cln3, Bck2 drives large cells into the cell cycle 25 . However, since Bck2 concentration is constant through G1 (Fig. 1e) , and the targets of this transcriptional regulator extend across the entire cell cycle 32, 33 , we decided to focus exclusively on the Cln3-Whi5 mechanism, which is specific for G1 progression, and performed subsequent analyses in a bck2D background. Cln3 pulse experiments. For the experiments shown in Fig. 4 , cells were grown on media lacking methionine, SCD-Met (MET25pr-mCitrine-CLN3-11A on). After 150 min of growth in the microfluidic device, 10 3 methionine was added to arrest cells in G1 (MET25pr-mCitrine-CLN3-11A off). After varying arrest times (2, 3, or 4 h for haploids, 3 h for diploids) methionine was removed for 0, 30, 40, 50, or 60 min (20, 30, 40, or 50 min for diploids) to induce a pulse of mCitrine-Cln3-11A expression. For daughter cells born during the experiment, we determined whether the cell budded during a 2 h time window following the onset of CLN3-11A induction. In addition, we measured the maximum Cln3-11A concentration. Cell size was measured at the time of maximum Cln3-11A concentration. For each strain, we then pooled all the data (22 independent experiments for haploids, 6 for diploids) and binned cells according to their size. For each size bin, we used a logistic regression to calculate the critical mCitrine-Cln3-11A concentration where 50% of the cells bud. To determine the median Whi5 concentration as a function of cell size we arrested MET25pr-CLN3-11A bck2D WHI5-mCitrine cells and measured Whi5 concentration as a function of cell size during the arrest (Extended Data Fig. 8 ). Error bars for Fig. 4c were calculated as the maximum of the 95% confidence interval of the logistic regression and the estimated experimental error due to variation in fluorescence intensity from experiment to experiment. We used a linear regression model to test whether ploidy affects the relationship between Whi5 and critical Cln3-11A concentrations. For the experiments shown in Fig. 4e and Extended Data Fig. 8 , we used a hormone-inducible LexApr 34 to express a Whi5-mCherry allele to decouple cell size and Whi5 concentration. We induced Whi5 by addition of b-oestradiol (30-100 nM) for at least 6 h, and removed b-oestradiol before the experiment. This allowed us to generate cells of varying size and Whi5 concentration by varying the induction level of Whi5 and the duration of G1 arrest (2, 2.5, or 3 h; 18 independent experiments) before the Cln3-11A pulse induction in SCD-Met. Growth conditions. For microscopy-based experiments, yeast were grown in synthetic complete media with 2% glycerol and 1% ethanol except for the pulse experiments shown in Fig. 4 , where yeast were grown on synthetic complete media with 2% glucose. Before an imaging experiment, cells were grown to an absorbance ,0.1 after which they were sonicated for ,5 s at 3 W intensity. For quantitative immunoblots, cells were grown on synthetic complete 2% galactose 2% raffinose overnight before being arrested in synthetic complete 2% glucose. Strains and plasmids. All strains were congenic with W303 (see Supplementary  Table 1 ), and were constructed using standard methods. See Supplementary Table  2 for plasmid list. To enable fluorescent Cln3 detection in live cells, it was necessary to use a stabilized variant of the protein. Stabilizing Cln3 by removing its degradation-inducing phosphosites 18 (Cln3-10A) allowed direct observation of Cln3-10A-mCitrine. However, induction of this stabilized variant with the MET25 LETTER RESEARCH promoter resulted in severe cytokinesis defects. We therefore added an additional mutation (R108A), which was reported to increase protein stability, but reduce the ability of Cln3 to drive cell cycle progression 19 . Also, R108A has been examined in the context of the double mutant K106A R108A (see variant Cln3-A10 in ref. 35 ) that increased steady state protein levels, but was less able to rescue a cln1D cln2D cln3D bck2D strain. Cln3-A10 was also reported to decrease the interaction with Cdc28 in ref. 36 (where it is known as the Cln3-A13 mutation). Combining the ten stabilizing alanine mutations from ref. 18 with the R108A mutation from ref. 19 resulted in a stabilized, less active Cln3 protein (Extended Data Fig. 1b) , which we refer to as Cln3-11A, whose concentration and amount were measurable in single cells without disrupting cytokinesis. For Figs 1b and 2a , we measured the concentration of Cln3 protein expressed from a previously characterized stabilized C-terminal truncation allele CLN3-1 (refs 20, 37) . Quantitative Whi5 immunoblot. Strain JTY6 (cln1Dcln2Dcln3D GAL1pr-CLN1 WHI5-3 3 Flag) was generated using plasmid pMK15 digested with MluI (New England BioLabs). Cells were grown at 30uC to mid-log phase (absorbance at 600 nm 5 0.2) in synthetic complete media with 2% galactose and 2% raffinose before being washed once and resuspended in an equal volume of synthetic complete with 2% glucose and incubated for 120 min at 30uC. Ten-millilitre samples were removed every 30 min for 150 min, and then every 45 min for 90 min thereafter. Samples were pelleted and frozen in liquid nitrogen. Concurrently, 1 ml samples were removed, sonicated, and analysed with a Coulter Z2 cell counter to measure cell size distributions with size cutoffs set at 30 and 500 fl.
Frozen cell pellets were thawed on ice, resuspended in 200 ml urea lysis buffer (20 mM TrisNCl pH 7.5, 7 M urea, 2 M thiourea, 65 mM CHAPS, 65 mM DTT, 50 mM NaF, 100 mM b-glycerophosphate, 1 mM NaVO 3 , 1 mM PMSF), and homogenized for 40 s at 4 uC in a FastPrep homogenizer (MP Biomedicals) using an equal volume of 0.5 mm diameter ceramic beads. Cell lysates were transferred to fresh microfuge tubes by puncturing the bottom of the tubes used for lysis, placing them in fresh tubes, and centrifuging for a few seconds at low speed. Lysates were then cleared by centrifuging at 17,000g for 10 min. Total protein concentration in the lysates was determined by Bradford analysis, and samples were diluted to a maximum volume of 12 ml in urea buffer, of which 10 ml were mixed with 5 ml 6 3 Laemmli sample buffer and run on a 12% (29:1) polyacrylamide gel. Gels were cut to include only the relevant molecular weight range, and proteins from all gels were transferred to a nitrocellulose membrane using program 8 for 7 min on an iBlot dry transfer device (Thermo Fisher Scientific). Membranes were blocked in Licor Odyssey blocking buffer (TBS; 927-50010) for 30 min at room temperature (,23 uC). Membranes were incubated with 1:1,000 M2 mouse monoclonal anti-Flag (Sigma F1804) and 1:5,000 rat monoclonal anti-tubulin YOL1/34 (Abcam ab6161) diluted in Licor Odyssey blocking buffer 1 0.2% Tween-20 for 60 min, and they were washed 1 3 15 min and 3 3 5 min in TBS 1 0.1% Tween-20. Membranes were then incubated in 1:15,000 goat anti-mouse conjugated to Alexa Fluor 680 (Thermo Fisher Scientific A-21058) and goat anti-rat conjugated to Licor IRDye 800CW (Licor, 925-32219) in the same buffer as for primary antibodies and washed as before. Membranes were imaged in a Licor Odyssey CLX-0670.
Immunoblot images were analysed by manually specifying band boundaries and measuring total intensity using Licor Image Studio Light. Background regions for each lane were also specified manually. These values were used to generate background-subtracted values, which were analysed with respect to mean population size using R. Extended Data Figure 1 | Size distributions of strains expressing mCitrine fusion proteins or CLN3 mutant alleles. a, Cell size distributions were measured in a Coulter counter for five strains expressing the indicated mCitrine fusion proteins from the endogenous locus and a WT control. These five strains were used in Fig. 1 . All strains were grown on synthetic complete 2% glycerol, 1% ethanol. b, Size distributions measured using a Coulter counter for cln3D cells expressing CLN3 alleles from a CLN3 promoter integrated at the URA3 locus. See Methods for description of CLN3 mutant alleles. Cells were grown on synthetic complete 2% glucose. Fig. 1f for display here. The relative change of Whi5 concentration during G1 is shown in grey (thin lines). Blue thick line shows the mean of all 339 cells. b, We randomly selected 40 out of 147 singlecell traces of Whi5 amount for display. Traces are aligned by bud emergence (t 5 0). G1 (cell birth to bud emergence) is shown in red (mean of all 147 cells is shown in blue). S/G2/M (bud emergence to cytokinesis) is shown in green (mean is shown in black). Black crosses denote time points of full nuclear Whi5 exit, blue crosses denote time points of full nuclear Whi5 re-entry. The rate of synthesis of Whi5 in S/G2/M phase is 6.6-fold higher than in G1 phase. Eightynine per cent of total Whi5 in this experiment is synthesized in S/G2/M. was expressed from a hormone-inducible promoter 34 (LexApr-WHI5-mCherry), which was inactivated before the experiment (see Fig. 4d, e ). The mean amount of Whi5-mCherry in G1-phase daughter cells was measured for each cell relative to its amount at t 5 0. The distance between the black arrows indicates the s.e.m. We estimated a half-life .6 h for cells grown in synthetic complete 2% glucose. b, c, mCitrine-Cln3-11A was expressed from a MET25 promoter for (b) 1 h on SC-Met 2% glucose or (c) .4.5 h on SC-Met 2% glycerol 1% ethanol. Next, transcription was inactivated by switching cells to media composed of either (b) synthetic complete 1 103 methionine 2% glucose or (c) synthetic complete 1 103 methionine 2% glycerol 1% ethanol. So that the cells had sufficient time to inactivate protein synthesis, we began our protein half-life measurement 21 min (33 min for synthetic complete 2% glycerol 1% ethanol) after methionine addition. Data and exponential fit shown for daughter cells in G1 phase. Black line indicates means; grey area indicates s.e.m. The short half-life of Cln3-11A relative to the doubling time of cell volume, together with the constant concentration of Cln3-11A through G1 ( Fig. 1-2) , implies that Cln3-11A synthesis is proportional to cell volume. To see this, consider the time-dependent equation for changes in Cln3
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where r is the rate of Cln3 protein synthesis (units of molecules 3 time 21 ), V is the cell volume, d is the degradation rate of Cln3 (units of time 21 ), and g is the rate of dilution of Cln3 due to cell growth (units of time 21 ). Since [Cln3] is constant, the left hand side 5 0. Also, the half-life of Cln3-11A is larger than that of Cln3, but much smaller than the time it takes to double the cell volume (,90 min on SCD, ,180 min on synthetic complete 2% glycerol 1% ethanol), so that d ? g. Thus, the equation simplifies to 0~r V {½Cln3|d so that the rate of Cln3 synthesis is proportional to cell volume, r~V|d|½Cln3. This is consistent with our estimates of Cln3-11A synthesis rates shown in Fig. 2g . a, Cell size distributions of WT (blue solid line) and hcm1D (red dashed line) cells, both carrying a WHI5-mCitrine allele, were measured in a Coulter counter. b, Size at Start as a function of birth size is shown for WT (n 5 339) and hcm1D (n 5 262) daughter cells. Bars denote mean and s.e.m. Note that small hcm1D cells exhibit poor size control (leftmost bin). c, Change in cellular Whi5 concentration during G1 for daughter cells. Cells are born at t 5 0 and the change in concentration is shown with s.e.m. Blue denotes WT (see also Fig. 1f ), red denotes hcm1D cells. d, Whi5 concentration at cell birth is shown as a function of cell size for WT (n 5 339) and hcm1D (n 5 284) daughter cells. e, The rate of Whi5 synthesis as a function of cell size is shown for WT (n 5 151) and hcm1D (n 5 106) cells. Bars denote mean values and s.e.m. Squares and circles denote single-cell data. f, The rate at which daughter cells progress through Start is shown as a function of Whi5-mCitrine concentration for WT (blue, n 5 334) and hcm1D (red, n 5 262) cells. Smooth lines are logistic regressions and the corresponding shaded areas denote 95% confidence intervals. Jagged lines connect means for binned data. Cells were grown on synthetic complete 2% glycerol 1% ethanol. Fig. 4 . a, Composite phase and fluorescence images of bck2D MET25pr-mCitrine-CLN3-11A haploid cells used in the pulse experiment shown in Fig. 4a -c. Cells were grown in the absence of methionine (MET25pr-mCitrine-CLN3-11A on). After 150 min (see image), cells were arrested in G1 by addition of 103 methionine to the SCD-Met medium. After variable lengths of arrest (3 h for the images shown here: see second image), a pulse of Cln3-11A was expressed by removal of methionine from the medium (1 h pulse for the experiment shown here: see third image). b, For daughter cells born during the experiment, we determined the maximum Cln3-11A concentration during the pulse, the corresponding cell volume, and whether the cell budded. Data from 22 different experiments were pooled. c, Cells were binned according to their size. For each 50 fl size bin, we used a logistic regression to calculate budding probability as a function of Cln3-11A peak concentration. d, For each size bin, the critical Cln3-11A concentration was determined as the amplitude of the pulse where 50% of the cells budded. A similar set of experiments was done for diploid cells; n 5 1195 for haploids, and n 5 405 for diploids. e, The bck2D MET25pr-CLN3-11A WHI5-mCitrine cells were arrested in G1 by addition of 103 methionine to the SCD-Met medium. Cells were tracked during the G1 arrest and the median Whi5-mCitrine concentration was measured as a function of size; n 5 162 for haploids, and n 5 148 for diploids. f, Single-cell data corresponding to Fig. 4e . MET25pr-mCitrine-CLN3-11A LexApr-WHI5-mCherry bck2D haploid cells were used for Cln3-11A pulse experiments to decouple cell size and Whi5 concentration. Maximum Cln3-11A concentration, corresponding cell size and Whi5 concentration, and whether or not the cell budded were determined in 18 independent experiments for a total of 471 daughter cells (see Methods). This generated a fourdimensional data set that we used build a logistic regression model. In this model, we predicted cell cycle entry (budding) using a linear combination of cell size, Whi5, and Cln3-11A. This resulted in a model based solely on Cln3-11A and Whi5. Thus, once Cln3-11A and Whi5 concentrations are measured, cell size yields no additional information. To visualize this result in Fig. 4e , we binned our data into six bins based on cell size (greater or less than 295 fl) and Whi5 concentration (,10, 10-25, and 25-40 arbitrary units). For each of these six bins, we performed a logistic regression to estimate the probability of entering the cell cycle as a function of the peak mCitrine-Cln3-11A concentration produced by the pulse. Fig. 1f . Increasing the time between frames from 3 min (n 5 339) to 10 min (n 5 75) did not significantly affect our concentration measurements, indicating that photobleaching of the mCitrine fluorescent protein was not significant in our experiments. b, Auto-fluorescent signal in the mCitrine channel during G1 arrest for an unlabelled strain (bck2D MET25pr-CLN3) in two independent experiments (blue: n 5 79; green: n 5 89). Cells were grown on SCD 1 103 methionine. Bars denote mean and s.e.m. for each size bin. The average of these two experiments was used for background subtraction in Fig. 4 . A similar size-dependent background subtraction was performed for each experimental condition and for the mCherry red fluorescent channel. c, Cell-to-cell variation in background-subtracted auto-fluorescence concentration measured in an unlabelled cell. One of the experiments with the unlabelled WT strain used to determine the autofluorescence signal for the experiments shown in Fig. 1-3 is analysed the same way as experiments shown in Fig. 2a, b (n 5 164) . This illustrates cell-to-cell variation in auto-fluorescence. Owing to experiment-to-experiment variation, a single control experiment with an unlabelled strain will typically result in a mean 'concentration' of 65 arbitrary units (compared with the average autofluorescence used for analysis), while cell-to-cell variability in autofluorescence within one experiment exhibits a standard deviation of ,10 arbitrary units. Note that the arbritary units in a and b are not comparable, because different settings were used to export the microscopy data for the pulse experiments shown in Fig. 4 .
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